Medicine recalls
|
| |
| Canada: Certain vials of fertility drug Cetrotide recalled because of potential contamination |
| |
Health Canada is advising Canadians that EMD Serono, a Division of EMD Inc. Canada, is recalling one lot of Cetrotide (Cetrorelix) 0.25mg (lot number: 8J025C) because some vials may have missing stoppers, which could make the product unsterile.
An unsterile product could introduce microorganisms when injected under the patient’s skin. This may result in a local infection, such as an abscess, or an infection of the skin and deeper underlying tissues (cellulitis). Some infections can be serious if they spread to the blood, bones, heart or other areas of the body. In addition, some of the contents of the vial may have spilled out because of the missing stopper, so the patient may not receive the proper dose and the drug would not be as effective.
Health Canada will monitor the company’s recall and inform Canadians if new safety information becomes available.
Please refer to the following website in Health Canada for details:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../73487a-eng.php
In Hong Kong, Cetrotide For Inj 0.25mg (HK-46953) is a registered pharmaceutical product containing cetrorelix. The product is registered by Merck Pharmaceutical (HK) Limited (Merck), and is a prescription-only medicine. As confirmed with Merck, the affected lot has not been imported into Hong Kong.
Ends/Monday, Jul 6, 2020
Issued at HKT 15:00
|
| |
